Your browser doesn't support javascript.
loading
N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.
Crozier, Jennifer A; Advani, Pooja P; LaPlant, Betsy; Hobday, Timothy; Jaslowski, Anthony J; Moreno-Aspitia, Alvaro; Perez, Edith A.
Affiliation
  • Crozier JA; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.
  • Advani PP; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.
  • LaPlant B; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Hobday T; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
  • Jaslowski AJ; Department of Hematology, Green Bay Oncology, Green Bay, WI.
  • Moreno-Aspitia A; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.
  • Perez EA; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL. Electronic address: perez.edith@mayo.edu.
Clin Breast Cancer ; 16(1): 23-30, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26381420

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Drug Resistance, Neoplasm Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Drug Resistance, Neoplasm Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States